Register for our free email digests:
Latest From Nestle SA
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in July and August 2017.
The trade group and food and drug attorney Scott Bass note FDA's interpretation of medical food stated in its guidance could undermine congressional intent for the category and limit the range of products firms can market as medical foods.
National University of Singapore researchers are looking for an industry partner to market their "gut-friendly" probiotic sour beer, signaling rising awareness in the research community regarding the opportunity for probiotics. Consultant Laura Mahecha discussed the growing probiotics market in a June 28 webinar hosted by Kline & Company.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Alcon Inc.
- Galderma SA
- Nestle Health Science SA
- Nestle HealthCare Nutrition
- Nestle Skin Health SA
- Nestle USA Inc.
- Novartis Medical Nutrition
- Owen-Galderma Laboratories Inc.
- Summit Autonomous Inc.
- Senior Management
Paul Bulcke, CEO
François-Xavier Roger, EVP, CFO
Stefan Catsicas, EVP, CTO & Head of R&D
- Contact Info
Phone: (41) 21 924 2111
avenue Nestlé 55
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.